What is FMED's relative strength rating?

Relative strength percentiles for FMED are not available for the current snapshot date. TickerStance publishes RS ratings daily after each session close; check back after the next pipeline run.

What sector is FMED in?

FMED is classified under the Other sector per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.

Is FMED in a leading sector?

Sector RS percentile is not available for Other at this snapshot. Leading sector status (threshold: Other RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.

How volatile is FMED?

Volatility metrics for FMED — average daily range (ADR%), average true range (ATR%), and beta — are not available for the current snapshot. These indicators update daily with each pipeline run.

Does FMED have a seasonal pattern?

TickerStance computes FMED's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what FMED has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did FMED last report earnings?

No SEC EDGAR filings are linked to FMED in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Fidelity Disruptive Medicine ETF (FMED)

Free

Dossier · Pro

Fidelity Disruptive Medicine ETF · Other

$32.26▼-0.82%

Neutral · stance 47.8As of Monday, August 24, 2026, posted ~17:00 ET

FMED is not confirmed as a leader.

3m RS is unavailable, Market Stance is 47.8

Lenses litMarket-wide RS; lit = leaderboard

3 month—pctile

6 month—pctile

1 year—pctile

Classic—IBD pctile

LDR—leadership

0 of 5 lenses litLens definitions methodology

Quality filters0 of 4 pass

ADR%—

A/D—

RVOL—

$ Vol—

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, Fidelity Disruptive Medicine ETF (FMED) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 47.8 (Neutral). Sector: Other. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

Filed: May 2026

HOLDINGS

Top holdings of FMED

Top 25 holdings of FMED by portfolio weight
#	Holding	Weight	Value
1	UCB SA	4.73%	$2M
2	LFST	4.27%	$2M
3	DHR	3.42%	$1M
4	TXG	3.11%	$1M
5	ISRG	2.92%	$1M
6	COGT	2.85%	$1M
7	ALNY	2.79%	$1M
8	ARGX	2.78%	$1M
9	LEGN	2.29%	$940K
10	UNH	2.25%	$922K
11	TECH	2.24%	$919K
12	EDWARDS LIFESCIENCES CORP	2.11%	$865K
13	MRNA	2.11%	$863K
14	KYMR	1.99%	$814K
15	XENE	1.92%	$786K
16	HTFL	1.89%	$774K
17	INSM	1.79%	$735K
18	VEEV	1.78%	$730K
19	PCVX	1.77%	$723K
20	RVMD	1.73%	$709K
21	CAI	1.71%	$702K
22	CRNX	1.65%	$675K
23	AXSM	1.57%	$645K
24	CYTK	1.55%	$634K
25	VCYT	1.54%	$631K

Showing 25 of 61 holdings.

CONCENTRATION

Portfolio shape

31.4%Top 10 holdings

61Total holdings

57 (93%)Resolved tickers

SECTORS

Sector breakdown

Healthcare

74.7%

Financials

3.5%

Technology

2.8%

Other

1.2%

Unclassified

8.3%

FAQ

Fund FAQ

What does FMED hold?: FMED holds 61 positions; its three largest are LFST (4.27%), DHR (3.42%), and TXG (3.11%) as of May 2026.
How concentrated is FMED?: The top 10 holdings account for 31.4% of FMED's portfolio. Moderately concentrated.
What sectors does FMED cover?: FMED's largest sector exposures are Healthcare (74.7%), Financials (3.5%), and Technology (2.8%).
How fresh is this data?: Holdings are sourced from SEC N-PORT-P filings, published quarterly with a ~60 day lag. The most recent filing for FMED is dated May 2026.

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

—

LDR

—

StageWeinstein stage analysis

—

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

A/D ratingaccumulation / distribution

—

RVOL todayvs 50d avg

—

U/D ratiolast 50 sessions

—

Breakout volbreakout day vs 50d avg

—

50d avg $ volumeliquidity proxy

—

Risk profile

How much does it move?

Daily range, ATR, beta, and the math for a 1-ADR stop.

ADR% (20d)avg daily range

—

ATR(14)14-day EMA

—

ATR%ATR as % of close

—

Beta vs SPY90d rolling

—

1-ADR stoprisk from close $32.26

—

Evidence · 3 of 3

Market backdrop

Pull-back risk if Macro turns < 60

Trend44.9Are the major indexes going up or down lately?30% weight Breadth50.6Is the rally broad-based or narrow?30% weight Leadership42.4Who's leading?20% weight Macro59.0What does the credit & rates environment say?20% weight

Stance47.8● Neutral

Public attention · FMED

Is the crowd watching?

No attention data for this ticker yet — it joins the daily scan once a baseline builds.

FAQ

Frequently asked questions

What is FMED's relative strength rating?: Relative strength percentiles for FMED are not available for the current snapshot date. TickerStance publishes RS ratings daily after each session close; check back after the next pipeline run.
What sector is FMED in?: FMED is classified under the Other sector per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data.
Is FMED in a leading sector?: Sector RS percentile is not available for Other at this snapshot. Leading sector status (threshold: Other RS ≥ 70th percentile) cannot be determined until the next sector RS pipeline run.
How volatile is FMED?: Volatility metrics for FMED — average daily range (ADR%), average true range (ATR%), and beta — are not available for the current snapshot. These indicators update daily with each pipeline run.
Does FMED have a seasonal pattern?: TickerStance computes FMED's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what FMED has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
When did FMED last report earnings?: No SEC EDGAR filings are linked to FMED in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Loading ticker…

Holding	Before → after	Δ weight
HTFLHEARTFLOW INC	— → 1.89%	—
RVMDREVOLUTION MEDICINES INC	— → 1.73%	—
AXSMAXSOME THERAPEUTICS INC	— → 1.57%	—
BTSGBRIGHTSPRING HEALTH SERVICES INC	— → 1.53%	—
VRDNVIRIDIAN THERAPEUTICS INC	— → 1.34%	—

Holding	Before → after	Δ weight
LFSTLIFESTANCE HEALTH GROUP INC	2.46% → 4.27%	+1.82 pp
TECHBIO TECHNE CORP	0.81% → 2.24%	+1.43 pp
TXG10X GENOMICS INC	1.70% → 3.11%	+1.41 pp
UNHUNITEDHEALTH GROUP INC	1.43% → 2.25%	+0.82 pp
XENEXENON PHARMACEUTICALS INC	1.11% → 1.92%	+0.81 pp

Holding	Before → after	Δ weight
BSXBOSTON SCIENTIFIC CORP	4.04% → 1.44%	−2.60 pp
WAYWAYSTAR HOLDING CORP	2.53% → 0.98%	−1.54 pp
PODDINSULET CORP	2.58% → 1.10%	−1.48 pp
VEEVVEEVA SYS INC	2.99% → 1.78%	−1.21 pp
ARGXARGENX SE	3.84% → 2.78%	−1.06 pp

Holding	Before → after	Δ weight
PENPENUMBRA INC	1.70% → —	—
ASCENDIS PHARMA A/S	1.48% → —	—
RMDRESMED INC	1.18% → —	—
CENTESSA PHARMACEUTICALS PLC	1.00% → —	—
DOCSDOXIMITY INC	0.64% → —	—

Holding	Before → after	Δ weight
HTFLHEARTFLOW INC	— → 1.89%	—
RVMDREVOLUTION MEDICINES INC	— → 1.73%	—
AXSMAXSOME THERAPEUTICS INC	— → 1.57%	—
BTSGBRIGHTSPRING HEALTH SERVICES INC	— → 1.53%	—
VRDNVIRIDIAN THERAPEUTICS INC	— → 1.34%	—

FMED is not confirmed as a leader.

Top holdings of FMED

Portfolio shape

Sector breakdown

Fund FAQ

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Market backdrop

Is the crowd watching?

Frequently asked questions

FMED is not confirmed as a leader.

§ Seasonality

Top holdings of FMED

Portfolio shape

Sector breakdown

What the holdings are doing

Between filings

Leaders inside FMED

Theme exposure inside FMED

Funds similar to FMED

Fund FAQ

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Market backdrop

Is the crowd watching?

Frequently asked questions

§ Seasonality

Funds similar to FMED

Between filings

Theme exposure inside FMED

Leaders inside FMED

What the holdings are doing

Ticker	Weight	Lens	Rank	Stage
LFST	4.27%	3M RS	171	Stage 2
TXG	3.11%	3M RS	17	Stage 2
COGT	2.85%	1Y RS	132	—
MRNA	2.11%	3M RS	6	Stage 2
KYMR	1.99%	1Y RS	162	Stage 2
HTFL	1.89%	1M RS	19	—
RVMD	1.73%	1Y RS	27	Stage 2
CAI	1.71%	1M RS	68	—
CRNX	1.65%	3M RS	30	Stage 2
NTRA	1.43%	3M RS	187	Stage 2

Fidelity Disruptive Medicine ETF (FMED) — Stance & relative strength

FMED is not confirmed as a leader.

Top holdings of FMED

Portfolio shape

Sector breakdown

Fund FAQ

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Market backdrop

Is the crowd watching?

Frequently asked questions

Fidelity Disruptive Medicine ETF (FMED) — Stance & relative strength

FMED is not confirmed as a leader.

Top holdings of FMED

Portfolio shape

Sector breakdown

What the holdings are doing

Between filings

Leaders inside FMED

Theme exposure inside FMED

Funds similar to FMED

Fund FAQ

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Market backdrop

Is the crowd watching?

Frequently asked questions

Funds similar to FMED

Between filings

Theme exposure inside FMED

Leaders inside FMED

What the holdings are doing